FDA Approves “Breakthrough” HIV Drug
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission of HIV, according to its manufacturer, Gilead Sciences. The drug, lenacapavir, will be sold under the name Yeztugo. “This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in a press […]
This post has been syndicated from Mother Jones, where it was published under this address.
FDA Approves “Breakthrough” HIV Drug Read Post »